N-[2-[(4R)-2,2-dimethyl-4-phenyloxan-4-yl]ethyl]-2-[(Z)-[(8S,9R,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ylidene]amino]oxyacetamide

C36H52N2O4 — CID 124901495

IUPACN-[2-[(4R)-2,2-dimethyl-4-phenyloxan-4-yl]ethyl]-2-[(Z)-[(8S,9R,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ylidene]amino]oxyacetamide
SMILESCC1(C)C[C@](CCNC(=O)CO/N=C2\C=C3CC[C@H]4[C@@H](CC[C@]5(C)[C@@H](O)CC[C@@H]45)[C@@]3(C)CC2)(c2ccccc2)CCO1
InChIInChI=1S/C36H52N2O4/c1-33(2)24-36(19-21-41-33,25-8-6-5-7-9-25)18-20-37-32(40)23-42-38-27-14-16-34(3)26(22-27)10-11-28-29-12-13-31(39)35(29,4)17-15-30(28)34/h5-9,22,28-31,39H,10-21,23-24H2,1-4H3,(H,37,40)/b38-27-/t28-,29+,30-,31+,34+,35+,36-/m1/s1
InChIKeyVZPAJJOLRAYDSO-XKIRUZMCSA-N
MW576.82 g/mol
LogP6.72
Rot. Bonds7

About N-[2-[(4R)-2,2-dimethyl-4-phenyloxan-4-yl]ethyl]-2-[(Z)-[(8S,9R,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ylidene]amino]oxyacetamide

N-[2-[(4R)-2,2-dimethyl-4-phenyloxan-4-yl]ethyl]-2-[(Z)-[(8S,9R,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ylidene]amino]oxyacetamide (PubChem CID 124901495) has the molecular formula C36H52N2O4 and a molecular weight of 576.82 g/mol. Its IUPAC name is N-[2-[(4R)-2,2-dimethyl-4-phenyloxan-4-yl]ethyl]-2-[(Z)-[(8S,9R,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ylidene]amino]oxyacetamide.

Molecular Properties

Compound NameN-[2-[(4R)-2,2-dimethyl-4-phenyloxan-4-yl]ethyl]-2-[(Z)-[(8S,9R,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ylidene]amino]oxyacetamide
PubChem CID124901495
Molecular FormulaC36H52N2O4
Molecular Weight576.82 g/mol
Exact Mass576.39
IUPAC NameN-[2-[(4R)-2,2-dimethyl-4-phenyloxan-4-yl]ethyl]-2-[(Z)-[(8S,9R,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ylidene]amino]oxyacetamide
SMILESCC1(C)C[C@](CCNC(=O)CO/N=C2\C=C3CC[C@H]4[C@@H](CC[C@]5(C)[C@@H](O)CC[C@@H]45)[C@@]3(C)CC2)(c2ccccc2)CCO1
InChIInChI=1S/C36H52N2O4/c1-33(2)24-36(19-21-41-33,25-8-6-5-7-9-25)18-20-37-32(40)23-42-38-27-14-16-34(3)26(22-27)10-11-28-29-12-13-31(39)35(29,4)17-15-30(28)34/h5-9,22,28-31,39H,10-21,23-24H2,1-4H3,(H,37,40)/b38-27-/t28-,29+,30-,31+,34+,35+,36-/m1/s1
InChIKeyVZPAJJOLRAYDSO-XKIRUZMCSA-N
XLogP6.72
TPSA80.15 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds7
Heavy Atoms42
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500576.82
LogP ≤ 56.72
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze N-[2-[(4R)-2,2-dimethyl-4-phenyloxan-4-yl]ethyl]-2-[(Z)-[(8S,9R,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ylidene]amino]oxyacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[2-[(4R)-2,2-dimethyl-4-phenyloxan-4-yl]ethyl]-2-[(Z)-[(8S,9R,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ylidene]amino]oxyacetamide?
The IUPAC name of N-[2-[(4R)-2,2-dimethyl-4-phenyloxan-4-yl]ethyl]-2-[(Z)-[(8S,9R,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ylidene]amino]oxyacetamide (CID 124901495) is N-[2-[(4R)-2,2-dimethyl-4-phenyloxan-4-yl]ethyl]-2-[(Z)-[(8S,9R,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ylidene]amino]oxyacetamide.
What is the SMILES notation for N-[2-[(4R)-2,2-dimethyl-4-phenyloxan-4-yl]ethyl]-2-[(Z)-[(8S,9R,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ylidene]amino]oxyacetamide?
The canonical SMILES for N-[2-[(4R)-2,2-dimethyl-4-phenyloxan-4-yl]ethyl]-2-[(Z)-[(8S,9R,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ylidene]amino]oxyacetamide is CC1(C)C[C@](CCNC(=O)CO/N=C2\C=C3CC[C@H]4[C@@H](CC[C@]5(C)[C@@H](O)CC[C@@H]45)[C@@]3(C)CC2)(c2ccccc2)CCO1.
What is the InChIKey of N-[2-[(4R)-2,2-dimethyl-4-phenyloxan-4-yl]ethyl]-2-[(Z)-[(8S,9R,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ylidene]amino]oxyacetamide?
The InChIKey is VZPAJJOLRAYDSO-XKIRUZMCSA-N. The full InChI is InChI=1S/C36H52N2O4/c1-33(2)24-36(19-21-41-33,25-8-6-5-7-9-25)18-20-37-32(40)23-42-38-27-14-16-34(3)26(22-27)10-11-28-29-12-13-31(39)35(29,4)17-15-30(28)34/h5-9,22,28-31,39H,10-21,23-24H2,1-4H3,(H,37,40)/b38-27-/t28-,29+,30-,31+,34+,35+,36-/m1/s1.
What are the key properties of N-[2-[(4R)-2,2-dimethyl-4-phenyloxan-4-yl]ethyl]-2-[(Z)-[(8S,9R,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ylidene]amino]oxyacetamide?
N-[2-[(4R)-2,2-dimethyl-4-phenyloxan-4-yl]ethyl]-2-[(Z)-[(8S,9R,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ylidene]amino]oxyacetamide has a molecular weight of 576.82 g/mol, XLogP of 6.72, 7 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-[(4R)-2,2-dimethyl-4-phenyloxan-4-yl]ethyl]-2-[(Z)-[(8S,9R,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ylidene]amino]oxyacetamide is sourced from PubChem (CID 124901495), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).